A call for global oversight of unproven stem cell therapies
2021-06-08
(Press-News.org) The promotion and marketing of unproven stem cell therapies is a global problem that needs a global solution, say experts in a perspective published June 8 in the journal Stem Cell Reports. The authors of the paper call for the World Health Organization (WHO) to establish an advisory committee on regenerative medicine to tackle this issue and provide guidance for countries around the world.
"The field of regenerative medicine, which entails the manipulation of cells and tissues to obtain therapeutic properties, has been hailed as the most promising research field in modern medicine," says senior author Mohamed Abou-el-Enein, the executive director of the joint University of Southern California/Children's Hospital of Los Angeles Cell Therapy Program. "Starting in the early 2000s, however, unregulated stem cell clinics offering untested and poorly characterized treatments with insufficient information on their safety and efficacy began emerging all over the world, taking advantage of the media hype around stem cells and patients' hope and desperation."
"Advancing regenerative medicine is key to addressing the chronic disease burden, which the WHO considers to be a top international priority," says first author Zubin Master, an associate professor of biomedical ethics at the Mayo Clinic. "And even though we have had significant advancement in the field of regenerative medicine, more needs to be done to ensure the safe and timely delivery of evidence-based interventions to patients, many of whom have exhausted all available options."
The three authors of the commentary are Lawrence Goldstein Science Policy Fellows for the International Society for Stem Cell Research (ISSCR) and ex-officio members of ISSCR's Public Policy Committee. They decided to write it after realizing that the majority of efforts in this space have focused on the marketing practices of providers and clinics, with much less focus on the tightening of regulations and enforcement to deal with the issue from a global standpoint.
The commentary highlights several proposals, including the harmonization of regulatory definitions surrounding stem cell and regenerative medicine and the importance of balancing the scientific evidence demonstrating safety and efficacy of stem cell and regenerative products with the needs of the patient.
"Many patients with chronic diseases who desire a regenerative medicine option have exhausted conventional medicine treatments and have no other suitable option," Master says. "We should aim to develop pathways to provide patients with evidenced-based experimental regenerative intervention as possible options where there is oversight, especially in circumstances where there is no suitable alternative left."
The authors write that the WHO, which already has established an expert advisory committee to develop global standards for governance and oversight of human genome editing, could initiate a similar committee to address the spread of unproven stem cell treatments. They say that the committee could promote greater harmonization among regulatory standards, convince member nations to prioritize this issue on their public health agendas, and develop educational and outreach tools that could help increase awareness among physicians and patients on the danger of this practice.
"I believe that the global spread of unproven stem cell therapies reflects critical gaps in the international system for responding to health crises, which could put the life of thousands of patients in danger," Abou-el-Enein says. "Urgent measures are needed to enhance the global regulatory capacity to detect and respond to this eminent crisis rapidly."
The authors also propose the establishment of an active surveillance mechanism to collect and analyze information on dubious clinics performing these procedures and share it with the public to increase awareness, as well as taking the appropriate legal actions. They note the importance of educational programs for patients and physicians on the realistic potential of stem cells and the regulatory pathways that are in place for developing these promising therapies.
INFORMATION:
Disclaimer: The opinions expressed here by Zubin Master are his own and are not representative of Mayo Clinic or any other organization.
Stem Cell Reports, Master et al.: "Unproven stem cell interventions: A global public health problem requiring global deliberation," https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(21)00255-1
Stem Cell Reports, published by Cell Press for the International Society for Stem Cell Research (@ISSCR), is a monthly open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. The journal focuses on shorter, single-point manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. Visit http://www.cell.com/stem-cell-reports. To receive Cell Press media alerts, please contact press@cell.com.
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-08
A new study has pinpointed a small group of cells in the brain which could be crucial to understanding how Alzheimer's disease begins and how to slow its progression. This discovery could help research into treatment for the disease by focusing on this key group of cells in the brain.
Alzheimer's disease is the most common type of dementia, affecting between 50 and 75 per cent of those diagnosed. There are currently around 850,000 people with dementia in the UK. This is projected to rise to 1.6 million by 2040.
"Alzheimer's disease evolves over decades but we currently lack an understanding of the events that take place in the early stages," explained Dr Diego Gomez-Nicola of the University of Southampton ...
2021-06-08
MELVILLE, N.Y., June 8, 2021 -- Variations in children's speech has traditionally been attributed to developmental delays. Recent work suggests the reasons for variability are not so clear, and an immediate call for treatment may need to be reconsidered.
During the 180th Meeting of the Acoustical Society of America, which will be held virtually June 8-10, Margaret Cychosz, from the University of Maryland, will discuss the need to better understand these variations. Her presentation, "Reconsidering variability in child speech production," will take place ...
2021-06-08
Neural replay during waking rest may contribute to memory consolidation of action sequences in humans, according to a study published June 8 in the journal Cell Reports. Brain imaging results revealed fast, repeated reactivation of a neural network representing a behavioral sequence that people were learning--approximately 20 times the speed of the new memory--especially while they were taking breaks from practice.
"This is the first demonstration of wakeful neural replay of a newly learned skill elicited by practice in humans," says senior study author Leonardo G. Cohen (@LeonardoGCohen) ...
2021-06-08
What The Study Did: The findings of this observational study of the association of race/ethnicity with COVID-19 infection rates and the interaction of pre-COVID experiences of food insecurity suggest that the association varied over time and across racial/ethnic groups.
Authors: Mare Sarr, Ph.D., of Pennsylvania State University in University Park, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.12852)
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media ...
2021-06-08
What The Study Did: This study tracked COVID-19 outcomes for 543 individuals with intellectual and developmental disabilities who were receiving support services from an organization providing residential services in the five boroughs of New York.
Authors: Scott D. Landes, Ph.D., of Syracuse University in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.12862)
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author ...
2021-06-08
What The Study Did: Researchers found differences in sociodemographic and clinical characteristics by entry location for SARS-CoV-2 testing within a safety-net health system. White and English-speaking individuals disproportionately initiated testing via telehealth visits, while Black, Native American and non-English-speaking patients disproportionately initiated testing through the emergency department.
Authors: Rohan Khazanchi, B.A,. Hennepin Healthcare Research Institute in Minneapolis, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.12857)
Editor's ...
2021-06-08
CHICAGO --- Some leaders in health care have called for an end to annual health check visits, saying they're a waste of time for patients and overworked primary care physicians and don't reduce the risk of death.
A new Northwestern Medicine study found while there is no clear proof that regular check-ups help adults live longer or prevent cardiovascular events like heart attacks or strokes, they still have many health benefits - especially for at-risk populations - and should continue.
Routine check-up visits (they don't have to necessarily be done annually) ...
2021-06-08
Decisions made now will determine whether economies win or lose money as the coal industry changes over the next couple of decades.
Countries including Australia and Indonesia could lose billions of dollars if they continue to invest in new coal mines and exports as the world moves away from fossil fuels.
These are the conclusions of a new analysis led by a team from Imperial College London and including researchers from Queen Mary University of London and Deloitte, which is published today in the journal Joule.
The team combined data on coal resources and demand in an economic model of trade and prices. ...
2021-06-08
BOSTON -- Death rates from chronic conditions like lung disease and cardiovascular disease and so-called "diseases of despair" such as opioid overdoses are known to be higher in rural areas than in large cities, with differing economic, social and political circumstances influencing people's access to care. To examine disparities in mortality rates for all causes of death, researchers from Brigham and Women's Hospital used a Centers for Disease Control and Prevention (CDC) database to analyze all deaths occurring in the U.S. between 1999 and 2019. They found that age-adjusted mortality rates (AAMRs) declined in both rural and urban populations, but that the gap between the death rates dramatically widened as white individuals aged 25 to ...
2021-06-08
Amyotrophic lateral sclerosis (ALS) is a severe, fatal neurodegenerative disorder causing loss of motor neurons and voluntary muscle action. While mouse studies have identified potential treatments, these drugs have typically done very poorly in human trials. Researchers at Boston Children's Hospital, working in collaboration with Pfizer, now report a high-throughput target and drug discovery platform using motor neurons made from ALS patients. Using the platform, they confirmed two known targets and identified an existing class of drugs -- agonists to the dopamine D2 receptor -- as potential novel treatments.
The researchers, led by Clifford Woolf, MD, PhD, director of the F.M. Kirby Neurobiology Center at Boston Children's, and first authors Xuan Huang, PhD, and Kasper Roet, PhD, ...
LAST 30 PRESS RELEASES:
[Press-News.org] A call for global oversight of unproven stem cell therapies
